Ipsen
Pharmaceuticals
IPN.PA
€ 94 2
Share price
$ 8.1 bn
Market Cap
$ 8.6 bn
Enterprise Value
Carbon footprint
Primary Climate Goal
Ipsen aims to reduce Scope 1 + 2 by 50% by 2030 from a base year 2019
This target has not been verified as science based according to SBTi
GHG emissions and Carbon intensity
Ipsen reported Total CO2e Emissions - Market-Based Scope 1 + Scope 2 for the twelve months ending 31 December 2021 at 19 Kt (-1.1 /-5.2% y-o-y). Also positively, carbon intensity decreased sharply to 5.4 t (-1.1 /-16.9% y-o-y).
Ipsen's Scope 3 emissions declined marginally to 32 Kt (
The company is committed to reducing Scope 1 + 2 by 50% by 2030 from a base year 2019, which translates into the estimated reduction of -0.76 Kt per annum over the period of FY2022 - FY2030. This target, however, has not been recognised as science-based (and as aligned with Paris Agreement) by the SBTi.
Copyright © 2022 Exerica. All rights reserved.